We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

76 hedge funds and large institutions have $410M invested in Aerie Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 36 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

414% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 7

200% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 8

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

27% more funds holding

Funds holding: 60 → 76 (+16)

4% more capital invested

Capital invested by funds: $392M → $410M (+$17.4M)

Holders
76
Holders Change
+16
Holders Change %
+26.67%
% of All Funds
2.2%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
24
Increased
36
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$19.2M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$16.7M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$9.9M
4
JP Morgan Chase
JP Morgan Chase
New York
+$4.85M
5
Stifel Financial
Stifel Financial
Missouri
+$3.86M

Top Sellers

Rank Fund Capital Flow
1
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
-$19.7M
2
BIT
BlackRock Institutional Trust
California
-$725K
3
WSA
Wall Street Associates
California
-$678K
4
BA
BlackRock Advisors
Delaware
-$401K
5
CS
Credit Suisse
Switzerland
-$277K
Name Holding Trade Value Shares
Change 		Change in
Stake
CCI
26
Columbus Circle Investors
$2.5M +$1.43M +72,588 +151%
State Street
27
State Street
Massachusetts
$2.49M +$229K +11,631 +11%
MSA
28
Mason Street Advisors
Wisconsin
$2.16M +$290K +14,690 +16%
BIT
29
BlackRock Institutional Trust
California
$2.1M -$725K -36,784 -27%
RA
30
Royce & Associates
New York
$2.07M +$1.97M +100,000 New
RSCM
31
Rock Springs Capital Management
Maryland
$2.06M +$1.96M +99,300 New
EI
32
EAM Investors
California
$1.91M +$1.24M +62,759 +211%
WA
33
Wasatch Advisors
Utah
$1.91M +$13.4K +679 +0.7%
JC
34
Jetstream Capital
Tennessee
$1.86M +$986K +50,000 +125%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$1.65M +$807K +40,931 +106%
Millennium Management
36
Millennium Management
New York
$1.64M +$851K +43,165 +119%
Geode Capital Management
37
Geode Capital Management
Massachusetts
$1.57M +$490K +24,831 +48%
HM
38
HealthCor Management
New York
$1.55M +$1.48M +75,000 New
USAA
39
United Services Automobile Association
Texas
$1.44M +$325K +16,491 +31%
RFC
40
Russell Frank Company
Washington
$1.39M +$851K +43,178 +179%
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$1.3M +$1.11M +56,481 +915%
HLA
42
Hamilton Lane Advisors
Pennsylvania
$1.28M +$1.22M +62,080 New
PIM
43
Platinum Investment Management
Australia
$1.22M +$1.16M +59,000 New
BCA
44
Benchmark Capital Advisors
New York
$972K +$927K +47,000 New
TCIM
45
TIAA CREF Investment Management
New York
$920K +$132K +6,700 +18%
Ameriprise
46
Ameriprise
Minnesota
$803K +$765K +38,796 New
TRSOTSOK
47
Teachers Retirement System of the State of Kentucky
Kentucky
$691K +$659K +33,410 New
Macquarie Group
48
Macquarie Group
Australia
$674K +$387K +19,606 +151%
BIM
49
BlackRock Investment Management
Delaware
$633K +$7.87K +399 +1%
NFA
50
Nationwide Fund Advisors
Ohio
$632K +$63.8K +3,238 +12%
1
2
3 4

AERI Hedge Fund Activity: Q3 2014 in Review

76 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q3 2014, worth a combined $410M — up 4.4% from $392M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new AERI positions and 8 closed out — a net gain of 16 holders — while 36 added to existing stakes and 7 trimmed.

The largest buyer was Deerfield Management, adding an estimated $19.2M. The largest seller was TPG Group Holdings (SBS) Advisors, cutting an estimated $19.7M.

  • 76 institutional investors held Aerie Pharmaceuticals (AERI) as of Q3 2014, up from 60 in Q2 2014.
  • Funds reported $410M of Aerie Pharmaceuticals stock for Q3 2014, up 4.4% quarter-over-quarter.
  • 24 funds opened new Aerie Pharmaceuticals positions in Q3 2014 and 8 closed out, a net change of +16 holders.
  • The largest Aerie Pharmaceuticals buyer in Q3 2014 was Deerfield Management, an estimated $19.2M added.
  • The largest Aerie Pharmaceuticals seller in Q3 2014 was TPG Group Holdings (SBS) Advisors, an estimated $19.7M sold.

Based on aggregated 13F filings for Q3 2014.